• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15934 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Simeprevir (Galexos — Janssen Inc.) indication: chronic hepatitis C genotype 1 infection
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Aclidinium bromide (Tudorza Genuair — Almirall Canada Ltd.) indication: chronic obstructive pulmonary disease
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) OnabotulinumtoxinA (Botox — Allergan Inc.) indication: chronic migraine
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Rotigotine (Neupro — UCB Canada Inc.) indication: idiopathic parkinson disease (early and advanced)
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Eplerenone (Inspra — Pfizer Canada Inc.) new indication: NYHA class II heart failure
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Use of new versus refurbished surgical tables: comparative clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Oral progesterone for the treatment of menopausal symptoms: clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Obesity management interventions delivered in primary care for patients with osteoarthritis: a review of clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Smoking cessation prior to surgery: clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Prevention of dehydration in geriatric patients in long-term care: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) The use of endotracheal tubes with subglottic secretion drainage to prevent ventilator-associated pneumonia: clinical effectiveness and safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) SmartSite bag access device: safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Computer-assisted interpretation of electrocardiograms: diagnostic accuracy and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous infusion pumps for transfusion of blood products: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Foot care for seniors in the community setting: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Techniques and products for surgical hand antisepsis: a review of guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Obesity management interventions delivered in primary care for patients with hypertension or cardiovascular disease: a review of clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Combination use of insulin and fipeptidyl peptidase-4 (DDP-4) inhibitors in Type 2 diabetes: clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Retrieval and redistribution of unused home care supplies: safety, cost-effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Eplerenone for NYHA functional class III/ IV heart failure and left-ventricular systolic dysfunction: clinical and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Off-label use of 5HT3 antagonists: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Nebulized Lidocaine for patients with nasal trauma: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Ankle braces for the prevention of injury in sport: clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Ketorolac for pain management: a review of the clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Cystoscopy for the diagnosis of patients with urological issues: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Interferon-free regimens for chronic hepatitis C genotype 1
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Obesity interventions delivered in primary care for patients with diabetes: a review of clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Interferon-free regimens for genotype 1 chronic hepatitis C: a review of the clinical evidence and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term 5HT3 antagonist use for schizophrenia: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Patient-controlled analgesia for pediatric surgical or cancer patients: clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Personal protective equipment for antibiotic resistant organisms in rehabilitation facilities: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term 5HT3 antagonist use for tinnitus: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for patients with genotype 1 chronic hepatitis C: a review of evidence-based guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Automated notification and reminder call systems: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Administration of naloxone in a home or community setting: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Continuous positive airway pressure for acute respiratory failure in the pre-hospital setting: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term 5HT3 antagonist use for alcohol dependence: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Management of massive blood transfusion in the rural setting: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Cryotherapy systems for wart removal: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Jewellery and the risk of bacteria transmission from healthcare worker to patient: clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Intranasal versus intravenous naloxone for opioid overdose in the pre-hospital setting: comparative clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Intrathecal bupivacaine via infusion pump for the management of pain: clinical evidence, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Electromagnetic interference between healthcare laser systems and sensitive electronic devices: safety and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Radiation emissions from computed tomography: a review of the risk of cancer and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Magnetic resonance imaging for patients with surgically implanted devices: safety and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Waterless wipes for chemical eye injuries: clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Therapeutic recreation for elderly and mental health patients: clinical benefit, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Emergency medical service "treat and release" protocols: a review of clinical and cost-effectiveness, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Balloon gastrostomy devices for adults: guidelines for replacement, maintenance, and training
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Electric shocks from conducted electric weapons: long-term clinical effects and guidelines for medical follow-up
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Autologous fat grafting for reconstructive surgery: a review of the clinical and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Oral intake in critical care patients: guidelines and recommendations
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Capnography and/or oximetry monitoring of patients using patient-controlled intravenous opioids: clinical and cost-effectiveness, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Periodic dental examinations for oral health: a review of clinical effectiveness, cost effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Dehumidifiers for reduction of humidity in operating rooms: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Personal wireless device use for wound care consultation: a review of safety, clinical benefits and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) High-fidelity simulation training for health care professionals: cost effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Mattresses for chronic back or neck pain: a review of the clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Appropriate use of hand-held wireless devices in healthcare settings: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Bivalirudin infusion following angioplasty: safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Stepwise approach for the prescription of opiates for non-cancer pain: a review of clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Nebulizers for the methacholine challenge test: diagnostic accuracy and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Intra-aortic balloon pumps for cardiac conditions: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Delivery of electroconvulsive therapy in non-hospital settings: a review of the safety and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Personal protection for visitors to patients on airborne precautions: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization of gauze for surgical procedures: clinical effectiveness, harms, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Lifestyle prescriptions: a review of the clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Home isolation to prevent tuberculosis transmission: a review of the clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Equipment required for medication nebulization: safety and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Fall prevention strategies for adults in outpatient programs: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Mobile apps for improving health: clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-manual techniques for room disinfection in healthcare facilities: a review of clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Contact investigations following patient and staff exposure to active tuberculosis infections: a review of the clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Oral progesterone for the treatment of menopausal symptoms: a review of the clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Vaginal micronized progesterone capsules for the prevention of miscarriage and preterm birth: a review of the clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Direct acting antivirals for chronic hepatitis C genotype 1 in select populations: emerging evidence of clinical effectiveness and safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Closed Intensive Care Units: Clinical and Cost-Effectiveness, Safety, and Guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Bariatric surgical procedures for obese and morbidly obese patients: a review of comparative clinical and cost-effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term use of ondansetron, dolasetron and granisetron for the prevention of nausea and vomiting: a review of the clinical effectiveness and safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Aspirating versus not aspirating prior to injection of medication: comparative clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) BMI reduction and chronic disease management: clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Suspended ceiling lifts: safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Anesthetic injections into the stellate ganglion for the treatment of hot flashes in women: a review of clinical and cost-effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal oxygen saturation range for adults suffering from traumatic brain injury: a review of patient benefit, harms, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Junctional tourniquets for controlling hemorrhage from wounds in adults: a review of clinical effectiveness, cost-effectiveness, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Antiemetics for adults experiencing opioid-induced nausea: a review of clinical and cost-effectiveness, benefits and harms, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Hearing protection fit testing systems: clinical and cost-effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Positive expiratory pressure devices and incentive spirometers for the prevention of pneumonia: comparative clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Use of chlorhexidine gluconate with alcohol for the prevention of peripheral intravenous device infections: a review of clinical and cost effectiveness, and guidelines
2014 HAYES, Inc. Applied behavior analysis-based interventions for autism spectrum disorder
2014 HAYES, Inc. Artificial disc replacement for cervical degenerative disc disease
2014 HAYES, Inc. Choline PET and PET-CT for suspected recurrent prostate cancer
2014 HAYES, Inc. Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening